SGLT2 Inhibitors and Pulmonary Arterial Hypertension: A Retrospective Study

被引：0
|
作者：
Abu-Rmaileh, M. [1 ]
Abu-Rmaileh, M. [1 ]
Hardin, E. [2 ]
Shah, T. [1 ]
Chin, K. M. [3 ]
机构：
[1] UTSW, Internal Med, Dallas, TX USA
[2] UTSW, Cardiol, Dallas, TX USA
[3] UT SouthWestern, Dallas, TX USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6119
引用
收藏
页数：2
相关论文
共 50 条
  • [31] SGLT2 Inhibitors: Mind the Gap
    Jiang, Chuan
    Palkar, Atul
    Caronia, Jonathan
    Gottesman, Eric
    CHEST, 2016, 150 (04) : 266A - 266A
  • [32] SGLT2 Inhibitors: Physiology and Pharmacology
    Wright, Ernest M.
    KIDNEY360, 2021, 2 (12): : 2027 - 2037
  • [33] The expanding resume of SGLT2 inhibitors
    de Boer, Ian H.
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (08): : 585 - 587
  • [34] Multiple Effects of SGLT2 Inhibitors
    Nagasu, Hajime
    JMA JOURNAL, 2024, 7 (04): : 580 - 581
  • [35] Cardiovascular safety of SGLT2 inhibitors
    Gumprecht, Janusz
    CLINICAL DIABETOLOGY, 2016, 5 (02): : 62 - 65
  • [36] SGLT2 Inhibitors and Renal Function
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1499): : 91 - 92
  • [37] SGLT2 inhibitors in clinical practice
    Ryden, Lars
    Norhammar, Anna
    LANCET DIABETES & ENDOCRINOLOGY, 2024, 12 (07): : 434 - 435
  • [38] SGLT2 inhibitors: β blockers for the kidney?
    Gilbert, Richard E.
    LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (10): : 814 - 814
  • [39] SGLT2 inhibitors and autophagy in diabetes
    Yaribeygi, Habib
    Maleki, Mina
    Atkin, Stephen L.
    Jamialahmadi, Tannaz
    Sahebkar, Amirhossein
    CELL BIOCHEMISTRY AND FUNCTION, 2023, 41 (04) : 392 - 398
  • [40] Benefits of SGLT2 inhibitors in arrhythmias
    Gao, Jinghan
    Xue, Genlong
    Zhan, Ge
    Wang, Xinying
    Li, Jiatian
    Yang, Xiaolei
    Xia, Yunlong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
12345